García-Álvarez, A., Blanco, I., García-Lunar, I., Jordà, P., Rodriguez-Arias, J. J., Fernández-Friera, L., . . . Ibáñez, B. (2023). β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): A double blind, placebo-controlled, randomized clinical trial.
Citación estilo ChicagoGarcía-Álvarez, Ana, et al. β3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Associated With Heart Failure (SPHERE-HF): A Double Blind, Placebo-controlled, Randomized Clinical Trial. 2023.
Cita MLAGarcía-Álvarez, Ana, et al. β3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Associated With Heart Failure (SPHERE-HF): A Double Blind, Placebo-controlled, Randomized Clinical Trial. 2023.